We are live on ! Find out more
STLNW icon

Starling Oncology Warrant

Delisted

STLNW was delisted on the 13th of November, 2026.

12 hedge funds and large institutions have $200K invested in Starling Oncology Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

99% less capital inflows, than outflows

Capital inflows: $3.17K | Capital outflows: $543K

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
1
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$1K

STLNW Hedge Fund Activity: Q3 2026 in Review

12 of the 8,114 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q3 2026, worth a combined $200K — down 72% from $707K a quarter earlier.

Fund positioning in STLNW was balanced in Q3 2026: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $2.4K. The largest seller was Oasis Management Company, exiting entirely with an estimated $543K sold.

  • 12 institutional investors held Starling Oncology Warrant (STLNW) as of Q3 2026, unchanged from Q2 2026.
  • Funds reported $200K of Starling Oncology Warrant stock for Q3 2026, down 72% quarter-over-quarter.
  • 1 fund opened new Starling Oncology Warrant positions in Q3 2026 and 1 closed out, a net change of 0 holders.
  • The largest Starling Oncology Warrant buyer in Q3 2026 was Wolverine Asset Management, an estimated $2.4K added.
  • The largest Starling Oncology Warrant seller in Q3 2026 was Oasis Management Company, an estimated $543K sold.

Based on aggregated 13F filings for Q3 2026.